Dermatologicals is anticipated to maintain current value growth in Brazil in the forecast period. Nappy (diaper) rash treatments is expected to continue to account for the largest share of sales within dermatologicals.
A survey by the pharmaceutical company Bayer showed that 52% of Brazilian women have had candidiasis at least once in their lives. This disease is caused by the fungus Candida albicans and is very common, affecting three out of four women.
In October 2023, the National Health Surveillance Agency (Anvisa) approved the first systematic treatment for alopecia areata, an autoimmune disease that causes hair loss. This means that baricitinib, also known by the trade name Olumiant (Eli Lilly do Brasil), can now be administered to adult patients with a severe form of the disease for whole-body treatment, rather than targeting a specific area.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Dermatologicals industry in Brazil with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Dermatologicals industry in Brazil, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Dermatologicals
Includes topical standard and herbal/traditional medicated products used to alleviate symptoms or treat skin or hair ailments. Exclude any systemic (oral) options to treat skin conditions or diseases.
See All of Our DefinitionsThis report originates from Passport, our Dermatologicals research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!